Most Read
Cabaletta Bio Reports Promising Rese-cel Data at EULAR 2026
Cabaletta Bio , a late-stage clinical biotechnology company focused on developing and…
Magazine
Profiles
Discover Categories
Everest Medicines Secures LNZ100 Deal in Greater China
Everest Medicines has signed an Asset Purchase Agreement with Corxel Pharmaceuticals to acquire the rights to develop, manufacture, and commercialize LNZ100 in Greater China, including mainland China, Hong Kong, Macau,…
✨ API China 2026 Highlights
Shanghai Yuanhuai Intelligent Technology Co., Ltd. showcased intelligent technology solutions at API China 2026, highlighting innovations driving industrial transformation and smart technology advancement.
